Cost-Sensitive KNN Algorithm for Cancer Prediction Based on Entropy Analysis.
1Department of Mathematics and Statistics, Huazhong Agricultural University, Wuhan 430070, China.
Entropy (Basel, Switzerland)
|February 25, 2022
Summary
Early cancer detection using blood protein markers offers a less invasive alternative to traditional methods. Analyzing serum protein entropy can significantly improve cancer recognition accuracy, aiding treatment and patient outcomes.
Area of Science:
- Biochemistry
- Medical Diagnostics
- Bioinformatics
Background:
- Early cancer diagnosis is crucial for effective treatment planning, improving survival rates and patient quality of life.
- Current methods like imaging and needle biopsy have limitations in early detection and can be invasive.
- Analyzing blood protein indexes offers a less invasive approach to monitor health status and detect cancer early.
Purpose of the Study:
- To investigate the potential of serum protein marker entropy analysis for early cancer detection.
- To develop and validate a cost-sensitive analysis model for improved cancer recognition accuracy.
- To explore the differences in serum protein marker complexity between normal and cancer patients.
Main Methods:
- Analysis of entropy differences in 39 serum protein marker sequences across different patient groups.
- Development of a cost-sensitive analysis model to enhance cancer recognition.
- Validation of the model on an imbalanced dataset (897 instances: 799 normal, 44 liver cancer, 54 ovarian cancer).
Main Results:
- Significant differences in serum protein marker entropy were observed between different cancer types.
- Serum protein marker complexity was found to be higher in normal individuals compared to cancer patients.
- The developed model achieved a high accuracy of 95.21% despite dataset imbalance, with strong precision (0.807), recall (0.833), F1 (0.819), and AUC (0.92).
Conclusions:
- Serum protein marker entropy analysis shows promise for early cancer prediction.
- The cost-sensitive model effectively improves cancer recognition accuracy, offering a valuable tool for clinical application.
- This research provides a foundation for intelligent medical treatment and non-invasive cancer diagnostics.
Related Concept Videos
Cancer Survival Analysis
473
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
473
Kaplan-Meier Approach
292
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
292
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Protein Networks
4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K


